| Name | Ethyl 4-(4-nitrophenyl)-1,3-thiazole-2-carboxylate |
|---|---|
| Synonyms |
ethylnitrophenylthiazolecarboxylate
ethyl 4-(4-nitrophenyl)-2-thiazolecarboxylate 4-p-Nitro-phenyl-2-carbethoxy-thiazol 2-(Ethoxycarbonyl)-4-(4-nitrophenyl)-1,3-thiazole 4-[2-(Ethoxycarbonyl)-1,3-thiazol-4-yl]nitrobenzene (2-ethoxycarbonylthiazol-4-yl)-4-nitrobenzene Ethyl4-(4-Nitrophenyl)thiazole-2-carboxylate |
| Molecular Formula | C12H10N2O4S |
|---|---|
| Molecular Weight | 278.28400 |
| Exact Mass | 278.03600 |
| PSA | 113.25000 |
| LogP | 3.41820 |
| HS Code | 2934100090 |
|---|
|
~94%
53101-04-5 |
| Literature: Gaikwad, Sudhakar A.; Patil, Amol A.; Deshmukh, Madhukar B. Phosphorus, Sulfur and Silicon and the Related Elements, 2010 , vol. 185, # 1 p. 103 - 109 |
|
~87%
53101-04-5 |
| Literature: SELEXAGEN THERAPEUTICS, INC.; VERNIER, Jean-Michel; MAY, John; O'CONNOR, Patrick; RIPKA, William; PINKERTON, Anthony; BOUNAUD, Pierre-Yves; HOPKINS, Stephanie Patent: WO2011/85128 A1, 2011 ; Location in patent: Page/Page column 54-55 ; |
|
~77%
53101-04-5 |
| Literature: BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BOEHRINGER INGELHEIM PHARMA GMBH and CO KG Patent: WO2004/65367 A1, 2004 ; Location in patent: Page 136 ; WO 2004/065367 A1 |
|
~75%
53101-04-5 |
| Literature: Boehringer Ingelheim (Canada) Ltd. Patent: US2003/236251 A1, 2003 ; Location in patent: Page 27 ; |
|
~%
53101-04-5 |
| Literature: Chemical & Pharmaceutical Bulletin, , vol. 43, # 9 p. 1497 - 1504 |
| Precursor 5 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |